Bae, SeungJin Professor

Pharmaceutical Sciences/Industrial Pharmaceutical Science/Division of Pharmacy

배승진 프로필 사진
Prof. SeungJin Bae is a renowned expert in the area of Pharmacoeconomics and pricing & reimbursement of pharmaceuticals. She has earned her doctoral degree from Harvard School of Public Health, Department of Health Policy and Management. She is currently being involved with topics including value of new drugs, reimbursement poliicy for oncology drugs, and quality-adjusted life years. She has published more than 15 papers in the international journals, and co-authored textbook titled "Administrative and Managerial Pharmacy". She was also principal investigator of various policy reports published by the Health Insurance Review and Accessment Service. 
Research Record
  • Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries BioDrugs, 2024, v.38 no.1, 133-144
    SCIE Scopus dColl.
  • Unveiling the Biosimilar Paradox of Oncologists’ Perceptions and Hesitations in South Korea: A Web-Based Survey Study BioDrugs, 2024, v.38 no.2, 301-311
    SCIE Scopus dColl.
  • Corporate social responsibility of pharmaceutical industry in Korea FRONTIERS IN PHARMACOLOGY, 2022, v.13, 950669
    SCIE Scopus dColl.
  • How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea Frontiers in Pharmacology, 2022, v.13, 884769
    SCIE Scopus dColl.
  • Impact and challenges of enactment for advanced regenerative medicine in South Korea FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, v.10, 972865
    SCIE Scopus dColl.
  • Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version Applied Health Economics and Health Policy, 2022, v.20 no.4, 467-477
    SCIE SSCI Scopus dColl.
  • Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea International Journal of Environmental Research and Public Health, 2022, v.19 no.5, 2494
    SCIE SSCI Scopus dColl.
  • The Impact of Payment Scheme Changes on Medication Adherence and Persistence of Patients Diagnosed with Depression in Korea International Journal of Environmental Research and Public Health, 2022, v.19 no.17, 11100
    SCIE SSCI Scopus dColl.
  • The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS BMC Health Services Research, 2022, v.22 no.1, 900
    SCIE Scopus dColl.
  • Computed tomographic measurements of the psoas muscle as a predictor of mortality in hip fracture patients: Muscle attenuation helps predict mortality in hip fracture patients Injury, 2021, v.52 no.6, 1456-1461
    SCIE Scopus dColl.
  • Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future Current Medical Research and Opinion, 2021, v.37 no.9, 1529-1545
    SCIE Scopus dColl.
  • How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements BMC Health Services Research, 2021, v.21 no.1, 967
    SCIE Scopus dColl.
  • Medication Adherence and Persistence of Open-Angle Glaucoma Patients in Korea: A Retrospective Study Using National Health Insurance Claims Data INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, v.18 no.8, 4106
    SCIE SSCI Scopus dColl.
  • Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, v.21 no.4, 527-540
    SCIE SSCI Scopus dColl.
  • Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, v.9, 737504
    SCIE Scopus dColl.
  • Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, v.36 no.29, e191
    SCIE Scopus KCI dColl.
  • The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future FRONTIERS IN PUBLIC HEALTH, 2021, v.9, 671961
    SCIE SSCI Scopus dColl.
  • Value Frameworks: Adaptation of Korean Versions of Value Frameworks for Oncology INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, v.18 no.6, 3139
    SCIE SSCI Scopus dColl.
  • A Meta-Regression Analysis of Utility Weights for Breast Cancer: The Power of Patients' Experience INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020 , 9412
    SCIE SSCI Scopus dColl.
  • Are Recently Evaluated Drugs More Likely to Receive Positive Reimbursement Recommendations in South Korea? 11-year Experience of the South Korean Positive List System CLINICAL THERAPEUTICS, 2020, v.42 no.7, 1222-1233
    SCIE Scopus dColl.
  • Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea BMC PUBLIC HEALTH, 2020, v.20 no.1, 0
    SCIE Scopus dColl.
  • Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate FRONTIERS IN PHARMACOLOGY, 2020, v.11, 232
    SCIE Scopus dColl.
  • Me-too validation study for in vitro skin irritation test with a reconstructed human epidermis model, KeraSkin™ for OECD test guideline 439 Regulatory Toxicology and Pharmacology, 2020, v.117, 104725
    SCIE Scopus dColl.
  • Modeling Healthcare Costs Attributable to Secondhand Smoke Exposure at Home among South Korean Children International journal of environmental research and public health, 2020, v.17 no.12
    SCIE SSCI Scopus dColl.
  • The Burden of Cervical Cancer in Korea: A Population-Based Study INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, v.17 no.17, 6308
    SCIE SSCI Scopus dColl.
  • Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries? Frontiers in Pharmacology, 2020, v.11, 970
    SCIE Scopus dColl.
  • Does the Patent Linkage System Prolong Effective Market Exclusivity? Recent Evidence From the Korea-US Free Trade Agreement in Korea INTERNATIONAL JOURNAL OF HEALTH SERVICES, 2019, v.49 no.2, 306-321
    SCIE SSCI Scopus dColl.
  • Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea HEALTH POLICY, 2019, v.123 no.4, 388-392
    SCIE SSCI Scopus dColl.
  • Evaluation of skin sensitization potential of chemicals by local lymph node assay using 5-bromo-2-deoxyuridine with flow cytometry Regulatory Toxicology and Pharmacology, 2019, v.107, 104401
    SCIE Scopus dColl.
  • Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study BMJ OPEN, 2019, v.9 no.9, e030930
    SCIE Scopus dColl.
  • Me-too validation study for in vitro eye irritation test with 3D-reconstructed human cornea epithelium, MCTT HCETM Toxicology in Vitro, 2019, v.55, 173-184
    SCIE Scopus dColl.
  • Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study BMJ OPEN, 2019, v.9 no.3, e026603
    SCIE Scopus dColl.
  • Statistical analysis of the reproducibility and predictive capacity of MCTT HCE™ eye irritation test, a me-too test method for OECD TG 492 Regulatory Toxicology and Pharmacology, 2019, v.107, 104430
    SCIE Scopus dColl.
  • Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, v.41 no.6, 1434-1441
    SCIE Scopus dColl.
  • Mental stress from animal experiments: A survey with Korean researchers Toxicological Research, 2018, v.34 no.1, 75-81
    Scopus KCI dColl.
  • Response to Letter to the Editor on our paper "Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4" by Ha et al. (Submitted 25 Jun 2017) REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2018, v.94, 325-329
    SCIE Scopus dColl.
  • Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4 Regulatory Toxicology and Pharmacology, 2017, v.85, 124-131
    SCIE Scopus dColl.
  • Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women BMJ Open, 2017, v.7 no.5
    SCIE Scopus dColl.
  • Prevalidation trial for a novel in vitro eye irritation test using the reconstructed human cornea-like epithelial model, MCTT HCE™ Toxicology in Vitro, 2017, v.39, 58-67
    SCIE Scopus dColl.
  • Real-world prescribing patterns of long-acting benzodiazepines for elderly Koreans in 2013 International Journal of Clinical Pharmacology and Therapeutics, 2017, v.55 no.6, 472-479
    SCIE Scopus dColl.
  • Eight-year experience of using HTA in drug reimbursement: South Korea HEALTH POLICY, 2016, v.120 no.6, 612-620
    SCIE SSCI Scopus dColl.
  • Exploration and comparison of in vitro eye irritation tests with the ISO standard in vivo rabbit test for the evaluation of the ocular irritancy of contact lenses TOXICOLOGY IN VITRO, 2016, v.37, 79-87
    SCIE Scopus dColl.
  • FACTORS ASSOCIATED WITH POTENTIALLY INAPPROPRIATE MEDICATION USE IN ELDERLY KOREANS IN AN OUTPATIENT SETTING: A POPULATION-BASED STUDY JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, v.64 no.9, E21-E23
    SCIE SSCI Scopus dColl.
  • Factors associated with potentially inappropriate medication use in elderly Koreans in an outpatient setting: A population-based study Journal of the American Geriatrics Society, 2016, 26 July 2016
    SCIE SSCI Scopus dColl.
  • Factors associated with the Career Preference of 6-Year Doctor of Pharmacy (Pharm.D) Students in Korea: a National Survey INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2016, v.50 no.3, 322-329
    SCIE Scopus dColl.
  • Metabolomic analysis of amino acids and lipids in human hair altered by dyeing, perming and bleaching Experimental Dermatology, 2016, v.25 no.9
    SCIE Scopus dColl.
  • Performance standard-based validation study for local lymph node assay: 5-bromo-2-deoxyuridine-flow cytometry method REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2016, v.80, 183-194
    SCIE Scopus dColl.
  • Predictive capacity of a non-radioisotopic local lymph node assay using flow cytometry, LLNA: BrdU-FCM: Comparison of a cutoff approach and inferential statistics Journal of Pharmacological and Toxicological Methods, 2016, v.78, 76-84
    SCIE Scopus dColl.
  • Appraisal of within- and between-laboratory reproducibility of non-radioisotopic local lymph node assay using flow cytometry, LLNA: BrdU-FCM: Comparison of OECD TG429 performance standard and statistical evaluation TOXICOLOGY LETTERS, 2015, v.234 no.3, 172-179
    SCIE Scopus dColl.
  • Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins JOURNAL OF DERMATOLOGICAL SCIENCE, 2015, v.77 no.1, 71-74
    SCIE Scopus dColl.
  • Same drugs, valued differently? Comparing comparators and methods used in reimbursement recommendations in Australia, Canada, and Korea HEALTH POLICY, 2015, v.119 no.5, 577-587
    SCIE SSCI Scopus dColl.
  • 중증질환 치료제에 대한 급여정책을 둘러싼 윤리적 쟁점 고찰 보건경제와 정책연구, 2015, v.21 no.1, 125-148
    KCI dColl.
  • Analysis of statistical methods currently used in toxicology journals Toxicological Research, 2014, v.30 no.3, 185-191
    KCI Scopus dColl.
  • KeraSkin™-VM: A novel reconstructed human epidermis model for skin irritation tests Toxicology in Vitro, 2014, v.28 no.5, 742-750
    Scopus dColl.
  • Sourcing Quality-of-Life Weights Obtained from Previous Studies: Theory and Reality in Korea PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2014, v.7 no.2, 141-150
    SCIE SSCI Scopus dColl.
  • Suppression of skin inflammation in keratinocytes and acute/chronic disease models by caffeic acid phenethyl ester Archives of Dermatological Research, 2014, 12 December 2014
    SCIE Scopus dColl.
  • 제약업계의 학사수준 신입인력 전공 선호도 연구 약 학 회 지, 2014, 제58권 6호, 397-404
    KCI dColl.
  • 한국, 호주, 캐나다, 영국의 항암제 및 희귀의약품의 접근성에 대한 고찰 보건경제와 정책연구, 2014, 제20권 2호, 1-20
    KCI dColl.
  • [학술지논문] Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries BIODRUGS, 2024, v.37 no.7 , 1-12
    SCIE
  • [학술지논문] Unveiling the Biosimilar Paradox of Oncologists’ Perceptions and Hesitations in South Korea: A Web-Based Survey Study BioDrugs, 2024, v.38 no.2 , 301-311
    SCIE
  • [학술지논문] Corporate social responsibility of pharmaceutical industry in Korea FRONTIERS IN PHARMACOLOGY, 2022, v.13 no.0 , 950669-950669
    SCIE
  • [학술지논문] For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, v.19 no.7 , 4204-4204
    SSCI
  • [학술지논문] How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea FRONTIERS IN PHARMACOLOGY, 2022, v.13 no.0 , 884769-884769
    SCIE
  • [학술지논문] Impact and challenges of enactment for advanced regenerative medicine in South Korea Frontiers in Bioengineering and Biotechnology, 2022, v.10 no.0 , 972865-972865
    SCIE
  • [학술지논문] Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2022, v.20 no.4 , 467-477
    SSCI
  • [학술지논문] Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, v.19 no.19 , 1-6
    SSCI
  • [학술지논문] Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, v.19 no.5 , 2494-2494
    SSCI
  • [학술지논문] The Impact of Payment Scheme Changes on Medication Adherence and Persistence of Patients Diagnosed with Depression in Korea INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, v.19 no.17 , 11100-11100
    SSCI
  • [학술지논문] The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS BMC HEALTH SERVICES RESEARCH, 2022, v.22 no.1 , 900-900
    SCIE
  • [학술지논문] Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future CURRENT MEDICAL RESEARCH AND OPINION, 2021, v.37 no.9 , 1529-1545
    SCI
  • [학술지논문] How can we improve patients' access to new drugs under uncertainties? : South Korea's experience with risk sharing arrangements BMC HEALTH SERVICES RESEARCH, 2021, v.21 no.1 , 967-967
    SCIE
  • [학술지논문] Medication Adherence and Persistence of Open-Angle Glaucoma Patients in Korea: A Retrospective Study Using National Health Insurance Claims Data INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, v.18 no.8 , 4106-4106
    SSCI
  • [학술지논문] Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, v.21 no.1 , 1-14
    SSCI
  • [학술지논문] Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement Frontiers in Bioengineering and Biotechnology, 2021, v.9 no.0 , 737504-737504
    SCIE
  • [학술지논문] The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future FRONTIERS IN PUBLIC HEALTH, 2021, v.9 no.0 , 671961-671961
    SSCI
  • [학술지논문] Value Frameworks: Adaptation of Korean Versions of Value Frameworks for Oncology INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, v.18 no.6 , 3139-3139
    SSCI
  • [학술지논문] A Meta-Regression Analysis of Utility Weights for Breast Cancer: The Power of Patients' Experience INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, v.17 no.24 , 9412-9412
    SSCI
  • [학술지논문] Are Recently Evaluated Drugs More Likely to Receive Positive Reimbursement Recommendations in South Korea? 11-year Experience of the South Korean Positive List System CLINICAL THERAPEUTICS, 2020, v.42 no.7 , 1222-1233
    SCI
  • [학술지논문] Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea BMC PUBLIC HEALTH, 2020, v.20 no.1 , 1-11
    SCIE
  • [학술지논문] Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate FRONTIERS IN PHARMACOLOGY, 2020, v.11 no.0 , 232-232
    SCIE
  • [학술지논문] Me-too validation study for in vitro skin irritation test with a reconstructed human epidermis model, KeraSkin (TM) for OECD test guideline 439 REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, v.117 no.0 , 104725-104725
    SCI
  • [학술지논문] Modeling Healthcare Costs Attributable to Secondhand Smoke Exposure at Home among South Korean Children INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, v.17 no.12 , 4496-4496
    SSCI
  • [학술지논문] The Burden of Cervical Cancer in Korea: A Population-Based Study INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, v.17 no.17 , 6308-6308
    SSCI
  • [학술지논문] Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries? FRONTIERS IN PHARMACOLOGY, 2020, v.11 no.0 , 970-970
    SCIE
  • [학술지논문] Does the Patent Linkage System Prolong Effective Market Exclusivity? Recent Evidence From the Korea-US Free Trade Agreement in Korea INTERNATIONAL JOURNAL OF HEALTH SERVICES, 2019, v.49 no.2 , 306-321
    SSCI
  • [학술지논문] Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea HEALTH POLICY, 2019, v.123 no.4 , 388-392
    SSCI
  • [학술지논문] Evaluation of skin sensitization potential of chemicals by local lymph node assay using 5-bromo-2-deoxyuridine with flow cytometry REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2019, v.107 no.0 , 104401-104401
    SCI
  • [학술지논문] Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study BMJ OPEN, 2019, v.9 no.9 , 030930-030930
    SCIE
  • [학술지논문] Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study BMJ OPEN, 2019, v.9 no.3 , 026603-026603
    SCIE
  • [학술지논문] Statistical analysis of the reproducibility and predictive capacity of MCTT HCE (TM) eye irritation test, a me-too test method for OECD TG 492 REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2019, v.107 no.0 , 104430-104430
    SCI
  • [학술지논문] Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, v.41 no.6 , 1434-1441
    SCI
Courses
  • 2024-2nd

    • Pharmaceutical Jurisprudence

      • Subject No 22491Class No 01
      • 5Year ( 1.5Credit , 1.5Hour) Wed 5~5 (PHM-A400)
      • Major Requisite
    • Pharmaceutical Jurisprudence

      • Subject No 22491Class No 02
      • 5Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A400)
      • Major Requisite
    • Pharmaceutical Jurisprudence

      • Subject No 22491Class No 03
      • 5Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A400)
      • Major Requisite
    • Pharmacy Administration

      • Subject No 37124Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Thu 3~3 (PHM-A404)
    • Pharmacy Ethics

      • Subject No 38932Class No 01
      • 2Year ( 1.5Credit , 1.5Hour)
      • Major Requisite
    • Pharmacy Ethics

      • Subject No 39037Class No 01
      • 2Year ( 1.5Credit , 1.5Hour)
      • Major Requisite
    • Project Analysis Ⅰ

      • Subject No G16659Class No 01
      • Year ( 3Credit , 3Hour) Fri 1~2 (PHM-)
    • Methods in Economic Evaluation in Pharmaceuticals Ⅰ

      • Subject No G16816Class No 01
      • Year ( 3Credit , 3Hour) Wed 6~7 (PHM-)
  • 2024-1st

    • Pharmacoeconomics

      • Subject No 37147Class No 01
      • 5Year ( 1.5Credit , 1.5Hour) Tue 4~4 (PHM-A404)
    • Industrial Pharmacy & Administrative Pharmacy Practice

      • Subject No 37153Class No 02
      • 6Year ( 2.5Credit , 160Hour)
      • Major Requisite
    • Honors research

    • Pharmaceutical Statistics

      • Subject No 39026Class No 01
      • 1Year ( 1.5Credit , 1.5Hour) Wed 5~5 (POSCO551)
      • Major Requisite
    • Pharmaceutical Statistics Computer Lab 강의 계획서 상세보기

      • Subject No 39027Class No 01
      • 1Year ( 1.5Credit , 1.5Hour) Wed 6~6 (POSCO159)
      • Major Requisite
    • Introduction to Pharmaceutical Research

      • Subject No 39045Class No 01
      • 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A100-1)
    • Seminar for Pharmaceutical Sciences Ⅲ 강의 계획서 상세보기

      • Subject No G16849Class No 01
      • Year ( 3Credit , 3Hour) Thu 7~8 (PHM-A-400)
    • Methods in Economic Evaluation in Pharmaceuticals Ⅱ

      • Subject No G17177Class No 01
      • Year ( 3Credit , 3Hour) Tue 6~7 (PHM-)
    • Seminar for Pharmaceutical Sciences Ⅲ 강의 계획서 상세보기

      • Subject No G18240Class No 01
      • Year ( 3Credit , 3Hour) Thu 7~8 (PHM-A-400)
  • 2023-2nd

  • 2023-1st

  • 2022-2nd

    • Pharmaceutical Jurisprudence

      • Subject No 22491Class No 01
      • 5Year ( 1.5Credit , 1.5Hour) Wed 5~5 (PHM-A400)
      • Major Requisite
    • Pharmaceutical Jurisprudence

      • Subject No 22491Class No 02
      • 5Year ( 1.5Credit , 1.5Hour) Thu 3~3 (PHM-A400)
      • Major Requisite
    • Pharmaceutical Jurisprudence

      • Subject No 22491Class No 03
      • 5Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A404)
      • Major Requisite
    • Pharmaceutical Jurisprudence

      • Subject No 22491Class No 04
      • 5Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A404)
      • Major Requisite
    • Pharmacy Administration

      • Subject No 37124Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Thu 2~2 (PHM-A404)
    • Pharmacy Administration

      • Subject No 37124Class No 02
      • 4Year ( 1.5Credit , 1.5Hour) Thu 2~2 (PHM-A404)
    • Advanced Pharmacy Practice and Research Ⅱ

      • Subject No 37155Class No 01
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Honors research

    • Lab rotation Ⅰ

      • Subject No 38927Class No 01
      • 1Year ( 1.5Credit , 0Hour) Thu 7~7
    • Lab rotation Ⅰ

      • Subject No 38927Class No 02
      • 1Year ( 1.5Credit Thu 7~7
    • Lab rotation Ⅰ

      • Subject No 39032Class No 01
      • 1Year ( 1.5Credit , 0Hour) Thu 7~7
    • Methods in Economic Evaluation in Pharmaceuticals I

      • Subject No G16816Class No 01
      • Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
  • 2022-1st

    • Pharmaceutical statistics

      • Subject No 37108Class No 01
      • 3Year ( 1.5Credit , 1.5Hour) Thu 6~6
      • Language Changed
    • Pharmacoeconomics

      • Subject No 37147Class No 01
      • 5Year ( 1.5Credit , 1.5Hour) Fri 3~3 (PHM-A404)
      • Language Changed
    • Pharmacoeconomics

      • Subject No 37147Class No 02
      • 5Year ( 1.5Credit , 1.5Hour) Fri 3~3 (PHM-A404)
      • Language Changed
    • Industrial Pharmacy & Administrative Pharmacy Practice

      • Subject No 37153Class No 02
      • 6Year ( 2.5Credit , 160Hour)
      • Major Requisite
    • Honors research

      • Subject No 37803Class No 01
      • 4Year ( 1Credit , 1Hour)
    • Pharmaceutical statistics

      • Subject No 38922Class No 01
      • 1Year ( 1.5Credit , 1.5Hour) Thu 5~5
      • Major Requisite,Language Changed
    • Pharmaceutical statistics

      • Subject No 39026Class No 01
      • 1Year ( 1.5Credit , 1.5Hour) Fri 5~5 (POSCO552)
      • Major Requisite,Language Changed
    • Pharmaceutical Statistics computer lab

      • Subject No 39027Class No 01
      • 1Year ( 1.5Credit , 1.5Hour) Fri 6~6 (POSCO159)
      • Major Requisite
    • Principles of Pharmaceutical Economics and Policy

      • Subject No G17175Class No 01
      • Year ( 3Credit , 3Hour) Fri 8~9 (-)
    • Social Pharmacy

      • Subject No CP530Class No 01
      • Year ( 3Credit , 3Hour) Wed 8~9 (ECC-)